(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
I work with companies to confront addiction in the workplace. The hidden crisis is costing corporate America millions. - 2The year's first meteor shower and supermoon clash in January skies
- 3Eating Brie, Gouda, cheddar may lower dementia risk, new study says
- 4Phonetic Associations: A Survey of \Interfacing Worldwide People group\ Language Trade Application
- 5NI economy losing momentum due to Iran crisis
- Artemis will take Americans to the moon for the 1st time since 1972. Why has it been so hard to go back?
- Tuesday, April 7. Russia’s War On Ukraine: News And Information From Ukraine
- Opening Achievement: 8 Methodologies for Compelling Using time productively
- I'm 18 and founded an AI startup. I have to wake up at 3 a.m. to work on it before school, but it's worth every sleepless night.
- Can humans have babies in space? It may be harder than expected
- A definitive Manual for Internet Mastering and Expertise Improvement
- Tzrifin base exhibition reveals Hamas and Hezbollah arms, showing structure behind attacks
- Closets for Your Room: Plan and Utility Features
- Faulty glucose monitors linked to 7 deaths and more than 700 injuries, FDA warns
